Your request to link to rcsb for BDBM36161
- 1YL8: 3d solution structure of [tyr3]octreotate derivatives in dmso (10.2174/1573406054864089 )
- 1YL9: 3d solution structure of [tyr3]octreotate derivatives in dmso (10.2174/1573406054864089 )
- 1IHT: crystal structure of the complex of human alpha-thrombin and non- hydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6 (10.1002/PROT.340170304 )
- 1IHS: crystal structure of the complex of human alpha-thrombin and non- hydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6 (10.1002/PROT.340170304 )
- 4GLS: crystal structure of chemically synthesized heterochiral {d-protein antagonist plus vegf-a} protein complex in space group p21 (10.1073/PNAS.1210483109 )
- 1NRQ: crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes (10.1021/BI00177A018 )
- 1TMB: molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide a (10.1073/PNAS.90.17.8048 )
- 1TMT: changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms
- 6KZF: racemic x-ray structure of calcicludine
- 1B0Q: dithiol alpha melanotropin peptide cyclized via rhenium metal coordination (10.1073/PNAS.95.22.12814 )
- 5E5T: quasi-racemic snakin-1 in p1 after radiation damage (10.1002/ANIE.201602719 )
- 5E5Y: quasi-racemic snakin-1 in p1 before radiation damage (10.1002/ANIE.201602719 )
- 5I1N: villin headpiece subdomain with a gln26 to beta-3-homoglutamine substitution (10.1021/JACS.6B01454 )
- 2JRY: structure and sodium channel activity of an excitatory i1- superfamily conotoxin (10.1021/BI700797F )
- 2RM9: astressin2b (10.1021/JA0760933 )
- 2RME: stressin (10.1021/JA0760933 )
- 2RMD: astressin-b (10.1021/JA0760933 )
- 2RMI: 3d nmr structure of astressin (10.1002/BIP.20818 )
- 5I5A: quasi racemic structure of allo-ile7-shk and d-shk (10.1002/ANIE.201612398 )
- 5I5B: quasi racemic structure of allo-thr13-shk and d-shk (10.1002/ANIE.201612398 )
- 5XDP: k11/48-branched teraubiquitin
- 2Q3I: crystal structure of the d10-p3/iqn17 complex: a d-peptide inhibitor of hiv-1 entry bound to the gp41 coiled-coil pocket (10.1016/S0092-8674(00)80066-5 )
- 2Q33: crystal structure of all-d monellin at 1.8 a resolution (10.1107/S0907444997012225 )
- 1MCJ: principles and pitfalls in designing site directed peptide ligands (10.1002/PROT.340160304 )
- 1MCI: principles and pitfalls in designing site directed peptide ligands (10.1002/PROT.340160304 )
- 1MCF: principles and pitfalls in designing site directed peptide ligands (10.1002/PROT.340160304 )
- 1MCE: principles and pitfalls in designing site directed peptide ligands (10.1002/PROT.340160304 )
- 1MCD: principles and pitfalls in designing site directed peptide ligands (10.1002/PROT.340160304 )
- 1MCC: principles and pitfalls in designing site directed peptide ligands (10.1002/PROT.340160304 )
- 1MCB: principles and pitfalls in designing site directed peptide ligands (10.1002/PROT.340160304 )
- 1MCS: principles and pitfalls in designing site directed peptide ligands (10.1002/PROT.340160304 )
- 2HGT: structure of the hirugen and hirulog 1 complexes of alpha-thrombin (10.1016/0022-2836(91)80132-E )
- 2JQB: solution structure of a novel d-amino acid containing conopeptide, conomarphin at ph 5
- 4K7T: structure of the ternary complex of bacitracin, zinc, and geranyl- pyrophosphate (10.1073/PNAS.1308268110 )
- 5CGO: structure of quasiracemic ala-magainin 2 with a beta amino acid substitution at position 13 (10.1021/JACS.5B07206 )
- 5CGN: structure of quasiracemic ala-magainin 2 with a beta amino acid substitution at position 8 (10.1021/JACS.5B07206 )
- 5CGH: yeast 20s proteasome beta5-g48c mutant in complex with alpha- chloroacetamide 5 (10.1002/ANIE.201506631 )
- 5J8P: lys27-linked diubiquitin
- 1GO9: monitoring the structural consequences of phe12-->d-phe12 and leu15-->aib15 substitution in h/r corticotropin releasing hormone: implications for design of crh antagonists. (10.1046/J.1432-1033.2002.03278.X )
- 1GOE: monitoring the structural consequences of phe12-->d-phe12 and leu15-->aib15 substitution in h/r corticotropin releasing hormone: implications for design of crh antagonists. (10.1046/J.1432-1033.2002.03278.X )
- 5GOH: lys33-linked di-ubiquitin (10.1021/JACS.6B09545 )
- 6B35: nmr ensemble of tyrocidine a analogue ac3.28 (10.1021/ACS.JMEDCHEM.7B00953 )
- 6B34: nmr ensemble of tyrocidine a analogue ac3.27 (10.1021/ACS.JMEDCHEM.7B00953 )
- 1SOC: nmr study of the backbone conformational equilibria of sandostatin, minimized average beta-sheet structure (10.1021/BI962497O )
- 2WPL: factor ixa superactive triple mutant, edta-soaked (10.1016/J.STR.2009.10.011 )
- 2WPI: factor ixa superactive double mutant (10.1016/J.STR.2009.10.011 )
- 2WPH: factor ixa superactive triple mutant (10.1016/J.STR.2009.10.011 )
- 2WPJ: factor ixa superactive triple mutant, nacl-soaked (10.1016/J.STR.2009.10.011 )
- 3TRY: crystal structure of racemic villin headpiece subdomain in space group i-4c2 (10.1021/JA210045S )
- 3IWY: crystal structure of human mdm2 complexed with d-peptide (12 residues) (10.1073/PNAS.1008930107 )
- 6FCE: nmr ensemble of macrocyclic peptidomimetic containing constrained a,a- dialkylated amino acids with potent and selective activity at human melanocortin receptors (10.1021/ACS.JMEDCHEM.8B00488 )
- 1PXQ: structure of subtilisin a (10.1021/BI0359527 )
- 4M6E: the high resolution structure of tyrocidine a reveals an amphipathic dimer (10.1016/J.BBAMEM.2014.01.033 )
- 4GLN: crystal structure of chemically synthesized heterochiral {d-protein antagonist plus vegf-a} protein complex in space group p21/n (10.1073/PNAS.1210483109 )
- 5XPK: crystal structure of ubiquitin-k6mimic
- 5JBV: lys27-linked triubiquitin
- 5JBY: lys27-linked triubiquitin
- 5GOB: lys6-linked di-ubiquitin (10.1021/JACS.6B09545 )
- 4KS6: crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s mutant with covalent inhibitor that modifies cys-165 causing disorder in 166-174 stretch
- 3MGN: d-peptide inhibitor pie71 in complex with iqn17 (10.1128/JVI.01339-10 )
- 1BFW: retro-inverso analogue of the g-h loop of vp1 in foot-and-mouth- disease (fmd) virus, nmr, 10 structures (10.1074/JBC.274.6.3686 )
- 5X3M: crystal structure of p-ub-s65-nh2
- 3U8R: human thrombin complexed with d-phe-pro-d-arg-ile (10.1371/JOURNAL.PONE.0034354 )
- 3U8T: human thrombin complexed with d-phe-pro-d-arg-cys (10.1371/JOURNAL.PONE.0034354 )
- 3U8O: human thrombin complexed with d-phe-pro-d-arg-d-thr (10.1371/JOURNAL.PONE.0034354 )
- 5X3O: crystal structure of p-diub-s65-cooh
- 5HHC: crystal structure of chemically synthesized heterochiral {rfx037 plus vegf-a} protein complex in space group p21/n (10.1021/ACSCHEMBIO.5B01006 )
- 5HHD: crystal structure of chemically synthesized heterochiral {rfx037 plus vegf-a} protein complex in space group p21 (10.1021/ACSCHEMBIO.5B01006 )
- 5E2L: 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from mycobacterium tuberculosis in complex with d-phenylalanine (10.1371/JOURNAL.PONE.0152723 )
- 2WW6: foldon containing d-amino acids in turn positions (10.1073/PNAS.1004187107 )
- 6BVX: sfti-hfrw-2 (10.1021/ACS.JMEDCHEM.8B00170 )
- 6BVY: sfti-hfrw-4 (10.1021/ACS.JMEDCHEM.8B00170 )
- 4TTK: racemic structure of sunflower trypsin inhibitor-1 (sfti-1) (10.1002/ANIE.201406563 )
- 6BVW: sfti-hfrw-3 (10.1021/ACS.JMEDCHEM.8B00170 )
- 2YYF: purification and structural characterization of a d-amino acid containing conopeptide, marmophine, from conus marmoreus (10.1111/J.1742-4658.2008.06352.X )
- 5E7Z: 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from mycobacterium tuberculosis in complex with d/l-tryptophan and d- phenylalanine (10.1371/JOURNAL.PONE.0152723 )
- 3GO0: crystal structure of d-enantiomer of human alpha-defensin 1 (d-hnp1) (10.1074/JBC.M109.018085 )
- 3UE7: x-ray crystal structure of a novel topological analogue of crambin (10.1002/ANIE.201107846 )
- 5GO7: linear tri-ubiquitin (10.1021/JACS.6B09545 )
- 5GO8: linear tetra-ubiquitin (10.1021/JACS.6B09545 )
- 5GOC: lys11-linked diubiquitin (10.1021/JACS.6B09545 )
- 5GOD: lys27-linked di-ubiquitin (10.1021/JACS.6B09545 )
- 5GOG: lys29-linked di-ubiquitin (10.1021/JACS.6B09545 )
- 5GOI: lys48-linked di-ubiquitin (10.1021/JACS.6B09545 )
- 5GOK: k11/k63-branched tri-ubiquitin (10.1021/JACS.6B09545 )
- 5GOJ: lys63-linked di-ubiquitin (10.1021/JACS.6B09545 )
- 6COS: csp1-f11 (10.1021/ACS.BIOCHEM.8B00653 )
- 3VVS: crystal structure of mate in complex with mad3s (10.1038/NATURE12014 )
- 3VVR: crystal structure of mate in complex with mad5 (10.1038/NATURE12014 )
- 2WPK: factor ixa superactive triple mutant, ethylene glycol-soaked (10.1016/J.STR.2009.10.011 )
- 1ABI: structure of the hirulog 3-thrombin complex and nature of the s' subsites of substrates and inhibitors (10.1021/BI00162A004 )
- 2SOC: nmr study of the backbone conformational equilibria of sandostatin, two representative minimum energy partially helical structures (10.1021/BI962497O )
- 2FMZ: carbonic anhydrase activators. activation of isoforms i, ii, iv, va, vii and xiv with l- and d- phenylalanine, structure with d- phenylalanine. (10.1021/JM0603320 )
- 3TRV: crystal structure of quasiracemic villin headpiece subdomain containing (f5phe17) substitution (10.1021/JA210045S )
- 3E0N: the x-ray structure of human prostasin in complex with dffr- chloromethyl ketone inhibitor (10.1002/PRO.118 )
- 2N7N: nmr structure of peptide pg-989 in dpc micelles (10.1021/ACS.JMEDCHEM.5B01285 )
- 5I1P: villin headpiece subdomain with a lys30 to beta-3-homolysine substitution (10.1021/JACS.6B01454 )
- 5I1S: villin headpiece subdomain with a lys30 to apc substitution (10.1021/JACS.6B01454 )
- 5I1O: villin headpiece subdomain with a gln26 to acpc substitution (10.1021/JACS.6B01454 )
- 4GLU: crystal structure of the mirror image form of vegf-a (10.1073/PNAS.1210483109 )
- 3VXF: x/n joint refinement of human alpha-thrombin-bivalirudin complex pd5 (10.1016/J.BBAPAP.2013.05.014 )
- 3VXE: human alpha-thrombin-bivalirudin complex at pd5.0 (10.1016/J.BBAPAP.2013.05.014 )
- 6MW2: cyclo-mle-phe-mle-d-phe. d-phe analogue of pseudoxylallemycin a. (10.1039/C9OB00227H )
- 6MW0: mle-phe-mle-d-phe. linear tetrapeptide related to pseudoxylallemycin a. (10.1039/C9OB00227H )
- 6BVU: sfti-hfrw-1 (10.1021/ACS.JMEDCHEM.8B00170 )
- 1TK2: crystal structure of the complex formed between alkaline proteinase savinase and gramicidin s at 1.5a resolution
- 1TKH: streptomyces griseus aminopeptidase complexed with d- phenylalanine
- 3TJW: crystal structure of quasiracemic villin headpiece subdomain containing (f5phe10) substitution (10.1021/JA210045S )
- 5YZD: crystal structure of the prefusion form of measles virus fusion protein in complex with a fusion inhibitor peptide (fip) (10.1073/PNAS.1718957115 )
- 2DNS: the crystal structure of d-amino acid amidase from ochrobactrum anthropi sv3 complexed with d-phenylalanine (10.1016/J.JMB.2006.10.070 )
- 6ANM: structure of d-leu-d-phe-2-abz-d-ala at 0.64 angstrom (10.1002/ASIA.201701422 )
- 4OIJ: x-ray crystal structure of racemic non-glycosylated chemokine ser-ccl1 (10.1002/ANIE.201400679 )
- 4OIK: (quasi-)racemic x-ray crystal structure of glycosylated chemokine ser- ccl1. (10.1002/ANIE.201400679 )